{
    "clinical_study": {
        "@rank": "153089", 
        "arm_group": {
            "arm_group_label": "Z-338", 
            "arm_group_type": "Experimental", 
            "description": "100mg TID"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this study is to evaluate the long-term safety of 100 mg Z-338 TID\n      in European subjects with FD."
        }, 
        "brief_title": "Phase III, Long-term, Open-label Safety Study of Z-338", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Dyspepsia", 
        "condition_browse": {
            "mesh_term": "Dyspepsia"
        }, 
        "detailed_description": {
            "textblock": "This is a Phase III, multicentre, single-arm, open-label study to evaluate the long-term\n      safety of 100 mg Z-338 TID in subjects with FD.\n\n      The study comprises a screening period (up to 3 weeks), a run-in period (1 week) and an\n      open-label treatment period (52 weeks). Including an additional 2-week follow-up period for\n      assessment of AEs, the maximum duration of a subject's participation in the study will be 58\n      weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects to provide written informed consent prior to any study procedures being\n             performed\n\n          -  Subjects with a diagnosis of FD (postprandial distress syndrome) as defined by the\n             Rome III Criteria\n\n          -  Subjects must present Postprandial Fullness or Early Satiation as the most bothersome\n             symptom during the 6 months prior to informed consent.\n\n          -  Subjects must have a normal endoscopy result within the 6 months (3 months in case of\n             subjects who are Helicobacter pylori positive) prior to informed consent or during\n             the screening period.\n\n        Exclusion Criteria:\n\n          -  Subjects on PPI(s) who are unable to discontinue PPI medication by the end of the\n             screening period\n\n          -  Subjects taking drugs that affect gut motility, gut sensitivity and/or acid secretion\n             who are unable to discontinue these drugs by the end of the screening period\n\n          -  Subjects who have received H. pylori eradication therapy during the 3 months prior to\n             informed consent\n\n          -  Subjects with confirmed organic gastrointestinal disease\n\n          -  Subjects presenting with predominant complaints relieved by stool movements\n             (irritable bowel syndrome)\n\n          -  Subjects presenting with predominant GORD symptoms\n\n          -  Subjects presenting with predominant complaints of chronic idiopathic nausea\n\n          -  Subjects with Type I or Type II diabetes\n\n          -  Subjects with body mass index (BMI) over 30 kg/m2\n\n          -  Subjects with any condition which, in the opinion of the Investigator, makes the\n             subject unsuitable for entry into the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "350", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01973790", 
            "org_study_id": "Z338-01"
        }, 
        "intervention": {
            "arm_group_label": "Z-338", 
            "description": "100mg TID", 
            "intervention_name": "Z-338", 
            "intervention_type": "Drug", 
            "other_name": "Acotiamide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Z-338", 
            "Functional Dyspepsia", 
            "Postprandial Distress Syndrome"
        ], 
        "lastchanged_date": "June 2, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Zeria Investigative PI", 
                    "phone": "+81356447053"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "Zeria Investigative site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigative PI"
                }, 
                "facility": {
                    "address": {
                        "city": "Riga", 
                        "country": "Latvia"
                    }, 
                    "name": "Zeria Investigative Sites"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigative PIs"
                }, 
                "facility": {
                    "address": {
                        "city": "Bratislava", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative sites"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigators"
                }, 
                "facility": {
                    "address": {
                        "city": "Kosice", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative sites"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Malacky", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Martin", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Nitra", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Nove Zamky", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Presov", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Trnava", 
                        "country": "Slovakia"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigative PI"
                }, 
                "facility": {
                    "address": {
                        "city": "Gothenburg", 
                        "country": "Sweden"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "investigator": {
                    "last_name": "Zeria Investigative PI", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigative PIs"
                }, 
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Zeria Investigative Sites"
                }, 
                "investigator": {
                    "last_name": "Zeria Investigative PI", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigative PI"
                }, 
                "facility": {
                    "address": {
                        "city": "Barnstaple", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Zeria Investigative site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Bath", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Zeria Investigative site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zeria Investigator"
                }, 
                "facility": {
                    "address": {
                        "city": "Leamington Spa", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Zeria Investigative Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Latvia", 
                "Slovakia", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase III, Multicentre, Single-arm, Open-label Study to Evaluate the Long-term Safety of Z-338 in Subjects With Functional Dyspepsia", 
        "overall_contact": {
            "last_name": "Zeria Pharmaceutical"
        }, 
        "overall_official": {
            "affiliation": "University of Leuven, University Hospital Gasthuisberg", 
            "last_name": "Jan Tack, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Slovakia: State Institute for Drug Control", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Latvia: State Agency of Medicines", 
                "Sweden: Medical Products Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Adverse Events, 12-lead ECGs, Laboratory variables, Vital signs, Physical examination", 
            "measure": "General safety endpoints", 
            "safety_issue": "Yes", 
            "time_frame": "up to 58 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01973790"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "the use of LPDS to measure FD symptom severity and the effect of Z-338, the effect of Z-338 on the QoL in subjects with FD as measured by SF-36 survey and SF-NDI, the effect of Z-338 on work productivity in subjects with FD as measured by WPAI.", 
            "measure": "To explore the efficacy", 
            "safety_issue": "No", 
            "time_frame": "up to 52 weeks"
        }, 
        "source": "Zeria Pharmaceutical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zeria Pharmaceutical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}